最終更新日：2024/08/07
(pharmacology) A short-acting modified recombinant form of insulin (a short-acting insulin analogue) administered by subcutaneous injection in the treatment of type 1 and type 2 diabetes. Trade names (trademarks) include NovoLog, Fiasp, and others.
正解を見る
insulin aspart
編集履歴（0）
元となった辞書の項目
insulin aspart
noun
